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Short Communication
Practice of use of antiemetic in patients for laparoscopic gynaecological surgery
and its impact on the early (1st two hrs) postoperative period
Samina Ismail
Department of Anaesthesia, Aga Khan University Hospital, Karachi.

Abstract
There is no agreed technique for minimizing PONV
(Postoperative Nausea and Vomiting) although some
techniques are associated with low rate. Best practice
involves identifying high risk patients and surgeries and use
of prophylactic antiemetic where appropriate. Laparoscopic
gynaecological surgery has high incidence of PONV (5492%). An audit on the practice of antiemetic use in
diagnostic laparoscopic gynaecological surgery was done in
the department of anaesthesia of Aga Khan University
Hospital from 1st January to 30th June 2006. We included
all the patients scheduled for this procedure lasting less than
90 minutes. Anaesthetist involved in the audit identified the
patient falling into the predetermined risk factors. The
following facts about antiemetic were noted; whether the
patients received any antiemetics or not, if it was
prophylactic or rescue, type, dose route and timing of
antiemetic. Patients were rated for any signs of nausea and
vomiting (retching) after extubation in the operating room
by the anaesthetist and in the recovery room or surgical day
care unit (SDC) by the nurse who was briefed about it and
was cross checked by the anaesthetist involved in the audit.
This was done for two hours postoperatively. Our results
showed that only 75% of patients with risk factors received
an antiemetic. The most commonly used antiemetic was
Metoclopramide. Eight percent of the patients had vomiting
and all of them had received a prophylactic antiemetic. They
received the same rescue antiemetic. This audit
recommended institutional guidelines for the management
of PONV. These should be based on evidence obtained from
the published peer-reviewed studies. These guidelines could
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be communicated to health care workers involved in
postoperative management of patients to help them achieve
an optimal management strategy for this uncomfortable
postoperative complication.

Introduction
Although the use of laparoscopic surgery for
gynaecological procedures has decreased surgical morbidity
and has become a popular procedure in an ambulatory
setting1, a high incidence of post operative nausea and
vomiting (PONV) (56-93%) has been reported in these
patients.2 PONV remains a major cause of delayed
discharge and patient dissatisfaction. In severe cases it can
lead to unanticipated hospital admission3 increasing cost to
patients, health care institution, and society.4
High rate of PONV in laparoscopy5 may be caused
by the gas used to "inflate" the abdomen to create work
place for the instruments. This puts pressure on the vagus
nerve, which has a connection to the brain's nausea and
vomiting centre. In addition to this, patients undergoing day
case gynaecological laparoscopy have a number of other
risk factors for PONV, as female gender, use of peroperative opioid and a journey home which is likely to
lower the threshold to motion-induced emesis.6
PONV continues to be a common problem despite
the replacement of older anaesthetic agents with short
acting and less emetogenic agents in conjunction with
surgical refinements. A lot has been said about PONV, the
med-line data base includes 100 publications on PONV
alone (4) but still the optimal approach to PONV remains
obscure to many clinicians. Unfortunately many clinical
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studies have used the surrogate end-points e.g. incidence
and severity of PONV without providing data on the
frequency of unanticipated admissions, post anaesthesia
care unit time and patient satisfaction.4 Therefore it can be
said that there is no agreed technique for minimizing PONV
although some techniques are associated with a lower
rate.7,8 According to consensus guidelines on managing
PONV9, the following steps need to be undertaken;
identification of the primary risk factors to reduce the
baseline risk for PONV, identifying the optimal approach
for prevention and therapy in various populations,
determining the optimal choice and timing of antiemetic
and identifying the most effective antiemetic monotherapy
and combination therapy regimen. A multimodal antiemetic approach can considerably reduce the incidence of
PONV in high risk patients and is associated with a high
patient satisfaction as measured by willingness -to -pay
method.4
We did an audit on the use of antiemetics in our
department, on patients scheduled for diagnostic
laparoscopic gynaecological surgery. Metoclopramide has
been well known for almost 40 years and is economical. It
has a potentially interesting molecule for the control of
PONV because of its triple antiemetic action.
It has also been investigated that antiemetics from
different pharmacologic drug groups should be used as a
rescue treatment, if prophylaxis with one group fails to
prevent PONV. We further wanted to see that whether the
use of antiemetic among the anaesthetist in our department
comply with the international recommendations or we need
to develop guidelines based on the current evidence, which
should be modified according to our circumstances and
patient population.

Patients Method and Results
We included all the patients scheduled for the
diagnostic laparoscopic gynecological surgery from 1st Jan
to 30th June 2006. Anaesthetist involved in the audit
identified the patients falling into the predetermined risk
factors, which were previous history of PONV or motion
sickness, level of anxiety according to the Amsterdam
preoperative anxiety and information scale (APAIS), age <
25 years, history of migraine, obesity with BMI > 30, nonsmoker, use of barbiturates induction agent, use of opioid
analgesics, use of N2O and pain in the operating and
recovery room. The following facts about antiemetic were
noted: if it was prophylactic or rescue, its name, dose, route
and timing (if it was given preoperatively in the ward,
waiting area or during surgery in the operating room or
postoperatively in the recovery room). Patients were rated
for any signs of nausea and vomiting (retching)
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postoperatively in the operating room by anaesthetist and in
the recovery or day care unit by the nurse who was briefed
about it. It was cross checked by the anaesthetist involved in
the audit. Monitoring was done for 2 hours in the recovery
room or day care unit .The scoring system used for PONV
was;
0 = None, 1 = mild nausea on inquiry, 2 = nausea without
inquiry, 3 = vomiting occurred, 4 = severe or repeated
vomiting.
Our results showed that forty eight patients had
underdone gynaecological laparoscopic surgery in six
months. Duration of surgery was between 30-90 minutes.
No surgery finished before 30 minutes or extended beyond
90 minutes. All patients had two or more risk factors.
Thirty six patients (75%) received prophylactic antiemetic
in the operating room twenty to thirty minutes before
extubation and twelve patients (25%) did not receive
prophylactic antiemetic. Metoclopramide was the only
antiemetic used in all cases. (Table and Graph) Four (8.3%)
patients had vomiting (score3) and all of them had received
prophylactic Metoclopramide for prophylaxis in the OR 20
- 30 minutes before extubation. One patient vomited in the
operating room after extubation (surgical time was 78
minutes), one in the recovery room (RR) at 30 minutes
(surgical time was 64 minutes) and two in the post surgical
day
care
unit
(SDC)
at
90
minutes
postoperatively.(surgical time 56 minutes and 75 minutes
respectively). Two patients who vomited complained of
accompanying pain and it was noted that co-analgesia like
non steroidal anti-inflammatory drug was not used in them.
The other two patients who vomited did not complain of
pain and co analgesia Ketorolac 30mg intravenous was
given to her in the operating room along with
Metoclopramide 20-30 minutes before extubation. In all
four patients Metoclopramide was used again as a rescue
antiemetic.
Table. Practice of use of antiemetic in patients coming for
Laparoscopic Gynaecological surgery.
Risk Factors

Metoclopramid Metoclopramide
e Used
Not Used

Previous H/O of PONV

4

0

Anxiety

24

5

Age < 25

6

1

H/O migraine

3

1

Obesity BMI > 30

4

1

Non Smoker

27

9

Use of Barbiturates induction agent

9

2

Use of opioid analgesics

38

10

Use of N2O

38

10

Pain in the OR and R/R

3

1
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Graph. Practice of use of antiemetic in pts coming for LaparoscopicGynaecological surgery.

Conclusion
We concluded that Metoclopramide 10 mg I/V was
the only antiemetic used both for prophylaxis and rescue. It
has been shown that Metoclopramide in this dose has no
proven antiemetic effect for PONV. As for rescue treatment
it is recommended to use antiemetics from different
pharmacological agents, if prophylaxis with one agent has
failed.
It is recommended that every institution should have
guidelines regarding antiemetic therapy and prophylaxis
based on peer-reviewed studies, and they should range from
no prophylaxis for patients at low risk to multimodal
antiemetic therapy for high risk patients. These guidelines
should also contain recommendations regarding rescue
therapy for break-through PONV with antiemetic of
different pharmacological agents if prophylaxis with one
agent has failed. This approach can help health care givers
to individualize prophylaxis and rescue therapy for their
patients to achieve an optimal management strategy for this
uncomfortable postoperative complication.
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